Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells

Table 1

VEGFR2 expression (cancer vs. normal) in other datasets of Oncomine.

Datasets	Subtype	value	-test	Fold change
Lu ovarian	Serous	0.007	-3.921	-1.622	20
	Mucinous	0.007	-3.453	-1.592	9
	Endometrioid	0.009	-3.514	-1.562	9
	Clear cell	0.013	-2.902	-1.480	7
TCGA ovarian	Serous	0.002	-3.997	-1.708	586
Yoshihara ovarian	Serous	8.33E-4	-3.460	-2.572	22
Adib ovarian	Serous	0.015	-3.044	-1.406	6
Hendrix ovarian	Serous	0.033	-2.580	-1.137	41
	Mucinous	0.118	-1.313	-1.078	13
	Endometrioid	0.058	-2.075	-1.107	37
	Clear cell	0.157	-1.095	-1.065	8

Notes: the bold font indicates the difference was significant statistically. The negative value of fold change represents that VEGFR2 expression was downregulated. : number of patients.